Sector dividends BriaCell Therapeutics Corp.
Stocks
BCT
CA1079303071
Biotechnology & Medical Research
|
Market Closed -
Toronto S.E.
23:59:51 31/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.970 CAD | -4.24% |
|
+3.11% | -49.29% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 31.19M | ||
| 1.44% | 1.6% | 20.25x | 4.77x | 7.09x | 14.33x | 16.22x | 68.13B | ||
| 0.04% | 0.08% | 36.11x | 7.56x | 9.4x | 28.68x | 29.2x | 63.6B | ||
| -.--% | -.--% | 29.63x | 3.16x | 6.32x | 16.43x | 19.67x | 25.57B | ||
| -.--% | -.--% | -74.57x | 37.31x | 14.38x | -69.34x | -83.45x | 26.6B | ||
| -.--% | -.--% | -15.53x | 1.26x | 5.87x | -7.38x | -5.81x | 25.52B | ||
| 0.29% | 0.17% | 52.62x | 13.09x | 19.47x | 39.5x | 42.66x | 18.23B | ||
| -.--% | -.--% | 26.84x | 3.16x | 5.04x | 16.75x | 18.87x | 19.69B | ||
| -.--% | -.--% | 1309.77x | 17.54x | 37.93x | 827.81x | -271.49x | 15.16B | ||
| -.--% | -.--% | 16.88x | 5.2x | 5.01x | 11.7x | 12.4x | 13.54B | ||
| -.--% | -.--% | -85.52x | 27.79x | 7.83x | -64.86x | -63.48x | 12.48B | ||
| -.--% | -.--% | -22.63x | 29.88x | 23.44x | -26.01x | -22.63x | 11.64B | ||
| -.--% | 0.01% | -527.35x | 7.92x | 14.35x | 493.55x | -382.9x | 10.56B | ||
| -.--% | -.--% | -11.62x | 39.73x | 2580.49x | -13.21x | -11.36x | 10.87B | ||
| -.--% | -.--% | -11.59x | -74.33x | 58.08x | -12.11x | -11.88x | 9.86B | ||
| -.--% | -.--% | -7.25x | - | - | -7.5x | -6.94x | 9.04B | ||
| -.--% | -.--% | 8.96x | 4.93x | 7.16x | 11.66x | 12.06x | 8.55B | ||
| -.--% | -.--% | -31.13x | 8.02x | - | -27.48x | -28.09x | 7.88B | ||
| Average | 0.1% | 0.11% | 41.99x | 8.56x | 186.79x | 72.50x | -43.35x | 19.83B | |
| Weighted average by Cap. | 0.3% | 0.33% | 45.53x | 9.00x | 94.31x | 52.11x | -20.24x |
- Stock Market
- Stocks
- BCT Stock
- Sector BriaCell Therapeutics Corp.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















